Impact of the COVID-19 pandemic on timeliness and equity of measles, mumps and rubella vaccinations in North East London: a longitudinal study using electronic health records

Impact of the COVID-19 pandemic on timeliness and equity of measles, mumps and rubella vaccinations in North East London: a longitudinal study using electronic health records

Objectives To quantify the effect of the COVID-19 pandemic on the timeliness of, and geographical and sociodemographic inequalities in, receipt of first measles, mumps and rubella (MMR) vaccination.Design Longitudinal study using primary care electronic health records.Setting 285 general practices i...

Full description

Bibliographic Details
Main Authors:	Carol Dezateux, Kate Homer, Nicola Firman, John Robson, Gill Harper, Zaheer Ahmed, Isabel Dostal, Crystal Williams, Ana Gutiérrez, Milena Marszalek
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-12-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/12/12/e066288.full

Similar Items

Are children who do not receive their first Measles Mumps and Rubella (MMR1) vaccination by 24 months more likely to share a household with older non-vaccinated children? Linked household-level analysis of primary care electronic health records (EHRs).
by: Milena Marszalek, et al.
Published: (2022-08-01)

Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
by: Zhifang Wang, et al.
Published: (2014-01-01)

Seroprevalence of measles, mumps, and rubella and genetic characterization of mumps virus in Khartoum, Sudan
by: Omer Adam, et al.
Published: (2020-02-01)

Clinical safety issues of measles, mumps and rubella vaccines
by: M.A. Afzal, et al.
Published: (2000-01-01)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
by: Heijstek MW, et al.
Published: (2008-09-01)

Implementation of a quality improvement programme using the Active Patient Link call and recall system to improve timeliness and equity of childhood vaccinations: protocol for a mixed-methods evaluation
by: Carol Dezateux, et al.
Published: (2023-01-01)

Science vs ‘‘scaremongering’’ over measles-mumps-rubella vaccine
by: Jacqui Wise
Published: (2001-01-01)

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
by: L Sticchi, et al.
Published: (2019-12-01)

Improving the Epidemiological Surveillance of Measles, Rubella and Mumps in the Russian Federation
Published: (2023-01-01)

Domestic Tetravaccine (Measles-Rubella-Mumps) – Immunization of Premature Babies
by: V. V. Semerikov, et al.
Published: (2022-09-01)

Measles, mumps, rubella vaccination experience in infants with egg allergy
by: Esra Hazar Sayar
Published: (2019-10-01)

The Investigation of Seroprevalence of Measles, Rubella, Mumps, and Varicella in Medical Students
by: Şebnem ÇALIK, et al.
Published: (2017-06-01)

Inadequate Measles, Mumps, Rubella, and Varicella Immunity Among Employees
by: Stephen Ezeji-Okoye, et al.
Published: (2021-04-01)

TIMELINESS AND LEVEL OF PRIMARY IMMUNIZATION COVERAGE AGAINST MEASLES AND RUBELLA IN MONTENEGRO
by: Branislav Tiodorović, et al.
Published: (2009-10-01)

Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients
by: Maddalena Casale, et al.
Published: (2021-05-01)

STATE OF MEASLES, RUBELLA AND MUMPS IN THE SARATOV REGION IN 2001—2013 YEARS
by: T. N. Buchkova, et al.
Published: (2015-08-01)

Partial third nerve palsy after Measles Mumps Rubella vaccination
by: Manzotti Francesca, et al.
Published: (2010-09-01)

Hubungan vaksin Measles, Mumps, Rubella (MMR) dengan Kejadian Autisme
by: Elsye Souvriyanti, et al.
Published: (2016-12-01)

Neuroimmunological approach for evaluation of viral measles, mumps and rubella triple vaccine
by: William Castillo González, et al.
Published: (2019-09-01)

Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart
by: Abbas Zamanian, et al.
Published: (2014-01-01)

Two cases of measles after vaccination with measles mumps and rubella combined live attenuated vaccine
by: SHEN Jinhua, et al.
Published: (2022-05-01)

Anticancer Activity of Measles–Mumps–Rubella MMR Vaccine Viruses against Glioblastoma
by: Zumama Khalid, et al.
Published: (2023-08-01)

Quality analysis of a combined domestic vaccine for the prevention of measles, rubella and mumps
by: Anna S. Binyatova, et al.
Published: (2022-11-01)

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink
by: Kayla E. Hanson, et al.
Published: (2023-04-01)

Safety of antibodies to measles, mumps, rubella and diphtheria in patients with juvenile idiopathic arthritis
by: I. V. Fridman, et al.
Published: (2021-07-01)

Measles, Rubella, Mumps and Chicken Pox Seroprevalence of Healthcare Workers in an Oncology Hospital
by: Gülşen İSKENDER, et al.
Published: (2020-09-01)

Seroprevalence of Hepatitis B, Measles, Mumps, Rubella, and Varicella in Health Care Workers
by: Zeynep TÜRE, et al.
Published: (2013-06-01)

Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management
by: Stefania Magistà, et al.
Published: (2020-11-01)

Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
by: Jeffrey E. Gold, et al.
Published: (2020-12-01)

A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents
by: Zary Nokhodian, et al.
Published: (2022-02-01)

Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA
by: Amy Parker Fiebelkorn, et al.
Published: (2013-09-01)

Are children living with obesity more likely to consult their general practitioner for knee pain? Longitudinal analysis of linked primary care and National Child Measurement Programme (NCMP) records.
by: Nicola Firman, et al.
Published: (2022-08-01)

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine
by: Nitin Shah, et al.
Published: (2024-12-01)

The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella
by: L. Jin, et al.

Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII
by: Barbara J. Kuter, et al.
Published: (2021-12-01)

THE INFLUENCE OF DOUBLE IMMUNIZATION ON MORBIDITY OF MEASLES, MUMPS AND RUBELLA IN THE NORTH-WEST REGION OF RUSSIA
by: L. V. Lyalina, et al.
Published: (2014-07-01)

Why Intralesional Measles-Mumps-Rubella is Superior to Bacillus Calmette-Guérin for Treatment of Warts?
by: Al Mutasim Al-Qassabi, et al.
Published: (2022-11-01)

Persistence in epidemic metapopulations: quantifying the rescue effects for measles, mumps, rubella and whooping cough.
by: C Jessica E Metcalf, et al.
Published: (2013-01-01)

Vaksinasi Measles, Mumps, dan Rubella (MMR) Sebagai Prophylaxis Terhadap COVID-19
by: Sajuni Widjaja
Published: (2020-06-01)

Dynamics of maternally transferred antibodies against measles, mumps, and rubella in infants in Sri Lanka
by: Nadhikala Muthiah, et al.
Published: (2021-06-01)